Prescription drug · ANDA
Sugammadex Sodium NDC 42023-830
Sugammadex sodium 200 mg/2mL · Solution · Intravenous · Par Health USA, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42023-830-10 | 42023083010 | 10 SYRINGE in 1 CARTON (42023-830-10) / 2 mL in 1 SYRINGEMarketed from Jul 28, 2026 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sugammadex Sodium
- Generic name (nonproprietary)
- sugammadex sodium
- Active ingredients
- Sugammadex sodium — 200 mg/2mL
- Dosage form
- Solution
- Route
- Intravenous
- Labeler
- Par Health USA, LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218814
- Marketing start
- Listing expires
- Other FDA classes
- gamma-Cyclodextrins (Chemical structure)
- Identifiers
- Product ID 42023-830_57d27f48-e8f1-531b-e063-6294a90ac2cbSPL ID 57d27f48-e8f1-531b-e063-6294a90ac2cbSPL set ID 579a2a1f-4d0c-4851-e063-6294a90a2be6RxCUI 2748156, 2748158UNII ERJ6X2MXV7
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N442023083010followed by a unit qualifier and the quantityPackage 42023-0830-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Sugammadex injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. Additional pediatric use information is approved for Merck Sharp & Dohme LLC’s BRIDION ® (sugammadex) injection. However, due to Merck Sharp & Dohme LLC’s marketing exclusivity rights, this drug product is not labeled with that information. Sugammadex injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. (1)
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 218814
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sugammadex Sodium | Sugammadex sodium 200 mg/2mL | SolutionIntravenous | STERISCIENCE SPECIALTIES PRIVATE LIMITED | 82449-241 |
| Sugammadex Sodium | Sugammadex sodium 500 mg/5mL | SolutionIntravenous | STERISCIENCE SPECIALTIES PRIVATE LIMITED | 82449-242 |
| Sugammadex Sodium | Sugammadex sodium 500 mg/5mL | SolutionIntravenous | Par Health USA, LLC | 42023-935 |